rs376103091

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong

The NM_001083614.2(EARS2):​c.322C>T​(p.Arg108Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,606,474 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

EARS2
NM_001083614.2 missense

Scores

1
8
10

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:12O:1

Conservation

PhyloP100: 3.54
Variant links:
Genes affected
EARS2 (HGNC:29419): (glutamyl-tRNA synthetase 2, mitochondrial) This gene encodes a member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of glutamate to tRNA molecules. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency 12 (COXPD12). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-23544677-G-A is Pathogenic according to our data. Variant chr16-23544677-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 39787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-23544677-G-A is described in Lovd as [Likely_pathogenic]. Variant chr16-23544677-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EARS2NM_001083614.2 linkc.322C>T p.Arg108Trp missense_variant Exon 3 of 9 ENST00000449606.7 NP_001077083.1 Q5JPH6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EARS2ENST00000449606.7 linkc.322C>T p.Arg108Trp missense_variant Exon 3 of 9 1 NM_001083614.2 ENSP00000395196.2 Q5JPH6-1

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152230
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000151
AC:
35
AN:
231208
Hom.:
0
AF XY:
0.000167
AC XY:
21
AN XY:
126014
show subpopulations
Gnomad AFR exome
AF:
0.0000729
Gnomad AMR exome
AF:
0.0000612
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000137
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000269
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000142
AC:
207
AN:
1454244
Hom.:
0
Cov.:
31
AF XY:
0.000152
AC XY:
110
AN XY:
722864
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.0000690
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000106
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000166
Gnomad4 OTH exome
AF:
0.000117
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152230
Hom.:
0
Cov.:
33
AF XY:
0.000175
AC XY:
13
AN XY:
74368
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000265
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000189
Hom.:
0
Bravo
AF:
0.000166
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000486
AC:
4
ExAC
AF:
0.000149
AC:
18

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:12Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome Pathogenic:5Other:1
Sep 01, 2022
3billion
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.015%). It is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense changes are a common disease-causing mechanism. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000039787). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least 2 similarly affected unrelated individuals (PMID: 22492562). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -

May 01, 2012
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

-
GenomeConnect, ClinGen
Significance: not provided
Review Status: no classification provided
Collection Method: phenotyping only

GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Dec 20, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: EARS2 c.322C>T (p.Arg108Trp) results in a non-conservative amino acid change located in the glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain (IPR020058) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00015 in 231208 control chromosomes. c.322C>T has been reported in the literature in multiple individuals affected with and/or with clinical features of Leukoencephalopathy-Thalamus And Brainstem Anomalies-High Lactate Syndrome (e.g. Steenweg_2012, Taylor_2014). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22492562, 25058219). Ten submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

Jan 14, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 14, 2023
Neuberg Centre For Genomic Medicine, NCGM
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The missense variant c.322C>T (p.Arg108Trp) in the EARS2 gene has been reported previously in heterozygous and compound heterozygous state in individuals affected with Leukoencephalopathy. It is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported (Steenweg et al., 2012; Taskin et al., 2016) Missense changes are a common disease-causing mechanism. This variant is reported with the allele frequency (0.01%) in the gnomAD and novel (not in any individuals) in the 1000 genome database. It is submitted to ClinVar with varying interpretations as Likely Pathogenic/ Pathogenic (Multiple Submissions). The amino acid Arginine at position 108 is changed to a Tryptophan changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted as damaging by SIFT. The amino acid change p.Arg108Trp in EARS2 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. -

not provided Pathogenic:4
Mar 29, 2022
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27571996, 27875839, 33855712, 33972171, 22492562, 26893310, 25058219, 27374853, 31520968, 34440436) -

Sep 13, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 108 of the EARS2 protein (p.Arg108Trp). This variant is present in population databases (rs376103091, gnomAD 0.03%). This missense change has been observed in individual(s) with combined oxidative phosphorylation deficiency (PMID: 22492562, 26893310). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 39787). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt EARS2 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -

Jun 07, 2017
Eurofins Ntd Llc (ga)
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Pathogenic:1
Sep 11, 2017
Ambry Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

See cases Pathogenic:1
Dec 21, 2022
Center for Personalized Medicine, Children's Hospital Los Angeles
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Seizure;C0235081:Limb tremor;C0240635:High palate;C0424503:Abnormal facial shape;C0494475:Bilateral tonic-clonic seizure;C0557874:Global developmental delay;C0857379:Abnormal pinna morphology;C1837260:Prominent forehead;C1854301:Motor delay Pathogenic:1
Jan 01, 2017
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.39
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.77
D;D;D;.
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.97
D;.;D;D
M_CAP
Benign
0.027
D
MetaRNN
Uncertain
0.43
T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.5
M;M;.;M
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-3.9
D;D;D;D
REVEL
Benign
0.19
Sift
Benign
0.11
T;T;T;T
Sift4G
Benign
0.18
T;T;T;T
Polyphen
0.99
D;D;.;.
Vest4
0.55
MVP
0.61
MPC
0.63
ClinPred
0.24
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.15
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs376103091; hg19: chr16-23555998; API